Pradofloxacin

Verify with FDA CVM →

592 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
592
Total Reports
79
Deaths Reported
1330.0%
Death Rate

Active Ingredients

Pradofloxacin

Administration Routes

OralUnknownParenteralTopicalOtherSubcutaneous

Species Affected

Cat 483
Unknown 91
Dog 12
Human 3
Cattle 2
Fallow 1

Most Affected Breeds

Domestic Shorthair 258
Unknown 95
Cat (unknown) 65
Domestic Longhair 46
Domestic Mediumhair 38
Siamese 16
Maine Coon 13
Persian 10
Cat (other) 7
Oriental 4

Most Reported Reactions

Behavioural disorder NOS 67
Vomiting 58
Hypersalivation 49
Lethargy (see also Central nervous system depression in 'Neurological') 48
Anorexia 47
Diarrhoea 46
Death by euthanasia 41
Death 38
Uncoded sign 35
Weight loss 34
Other abnormal test result NOS 33
Blindness 31

Outcome Breakdown

Outcome Unknown
208 (41.4%)
Recovered/Normal
157 (31.2%)
Ongoing
55 (10.9%)
Died
40 (8.0%)
Euthanized
40 (8.0%)
Recovered with Sequela
3 (0.6%)

Data Summary

Metric Value
Total adverse event reports 592
Reports involving death 79
Case-fatality rate (reported events) 1330.0%
Distinct species in reports 6
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Pradofloxacin Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 592 adverse event reports referencing Pradofloxacin, including 79 reports in which the animal died — a 1330.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Pradofloxacin. Reported administration routes include Oral, Unknown, Parenteral, Topical. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Pradofloxacin reports are Cat (483 reports), Unknown (91 reports), Dog (12 reports), with Cat accounting for the largest share. Within those species, Domestic Shorthair (258), Unknown (95), Cat (unknown) (65) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Pradofloxacin are Behavioural disorder NOS (67), Vomiting (58), Hypersalivation (49), Lethargy (see also Central nervous system depression in 'Neurological') (48). Of the 503 reports with a coded outcome, Outcome Unknown is the leading category at 41.4%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Pradofloxacin.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial